Myriad Genetics, Inc. MYGN recently made SneakPeek available over the counter in more than 8,800 retail locations nationwide.

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

If you or your partner is currently pregnant, you’ll be thrilled you know there’s a new baby gender predictor on the market ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

No-cost testing services are now available at stores across the country as part of expanded partnership with the CDC and HHS To help improve access to fast, reliable testing for veterans, Walgreens is ...

October 31, 2024--(BUSINESS WIRE)--To help improve access to fast, reliable testing for veterans, Walgreens is now offering no-cost testing through a partnership with the Centers for Disease ...

To help improve access to fast, reliable testing for veterans, Walgreens is now offering no-cost testing through a partnership with the Centers for Disease Control and Prevention (CDC).* Eligible ...